Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniele Boccia"'
Autor:
Maria Cellerino, Simona Schiavi, Caterina Lapucci, Elvira Sbragia, Giacomo Boffa, Claudia Rolla-Bigliani, Serena Tonelli, Daniele Boccia, Nicolò Bruschi, Francesco Tazza, Diego Franciotta, Matilde Inglese
Publikováno v:
Frontiers in Neuroscience, Vol 17 (2023)
IntroductionThe subventricular zone (SVZ) represents one of the main adult brain neurogenesis niche. In-vivo imaging of SVZ is very challenging and little is known about MRI correlates of SVZ macro- and micro-structural injury in multiple sclerosis (
Externí odkaz:
https://doaj.org/article/a3c5727444734e029be6f6ae3eae0b96
Autor:
Vincenzo Daniele Boccia, Caterina Lapucci, Maria Cellerino, Francesco Tazza, Andrea Rossi, Simona Schiavi, Maria Margherita Mancardi, Matilde Inglese
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England).
The central vein sign (CVS) has been proposed as a biomarker of multiple sclerosis (MS). In adult-onset MS (AOMS), 40%-threshold of CVS positive (+) lesions demonstrated high accuracy for MS diagnosis. However, CVS+ lesions’ performance has not bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54068889ea529ed4ff09a202343e505b
https://pubmed.ncbi.nlm.nih.gov/36514274
https://pubmed.ncbi.nlm.nih.gov/36514274
Autor:
Raffaele Dubbioso, Marco Bove, Daniele Boccia, Vincenzo D’Ambrosio, Maria Nolano, Fiore Manganelli, Rosa Iodice
Background Hand dexterity impairment is a key feature of disability in people with primary progressive multiple sclerosis (PPMS). So far, ocrelizumab, a recombinant humanized monoclonal antibody that selectively depletes CD20-expressing B cells, is t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08413de70222d653b50a9675acd2f82b
http://hdl.handle.net/11588/883185
http://hdl.handle.net/11588/883185
Autor:
Pietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, Damiano Paolicelli, Emilio Portaccio, Matilde Inglese, Matteo Foschi, Francesco Patti, Franco Granella, Silvia Romano, Paola Cavalla, Giovanna De Luca, Paolo Gallo, Paolo Bellantonio, Antonio Gallo, Sara Montepietra, Alessia Di Sapio, Marika Vianello, Rocco Quatrale, Daniele Spitaleri, Raffaella Clerici, Valentina Torri Clerici, Eleonora Cocco, Vincenzo Brescia Morra, Girolama Alessandra Marfia, Vincenzo Daniele Boccia, Massimo Filippi, Maria Pia Amato, Maria Trojano, the Italian MS Register
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 11, Iss 8, Pp 2008-2015 (2024)
Abstract Objective No direct comparisons of the effect of natalizumab and ocrelizumab on progression independent of relapse activity (PIRA) and relapse‐associated worsening (RAW) events are currently available. We aimed to compare the risk of achie
Externí odkaz:
https://doaj.org/article/d5e45aa5f4bd4d6c8e2fa3b80816e126